China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.79 | 0.11 | -0.27 | 0.25 |
| FCF Yield | 0.00% | 13.99% | 2.18% | 10.20% |
| EV / EBITDA | 29.31 | 20.11 | 19.41 | 16.01 |
| Quality | ||||
| ROIC | -0.11% | -0.24% | 0.88% | 3.01% |
| Gross Margin | 48.70% | 46.71% | 48.43% | 51.21% |
| Cash Conversion Ratio | – | -42.06 | 2.70 | 2.53 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.43% | 5.94% | 9.24% | 8.23% |
| Free Cash Flow Growth | -100.00% | 402.97% | -78.09% | 277.56% |
| Safety | ||||
| Net Debt / EBITDA | -1.98 | 0.24 | 2.07 | 1.96 |
| Interest Coverage | -1.31 | -0.21 | 0.00 | -15.55 |
| Efficiency | ||||
| Inventory Turnover | 0.41 | 0.91 | 0.77 | 0.72 |
| Cash Conversion Cycle | 306.28 | 145.29 | 160.84 | 160.88 |